The bleeding with antithrombotic therapy study 2: Rationale, design, and baseline characteristics of the participants

AIMS: The bleeding risk of current antithrombotic strategies in clinical settings, including recently developed agents, needs to be clarified. METHODS AND DESIGN: In an investigator-initiated, prospective, multicentre, observational study, patients with cerebrovascular or cardiovascular diseases who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Stroke J
Main Authors: Takagi, Masahito, Tanaka, Kanta, Miwa, Kaori, Sasaki, Makoto, Koga, Masatoshi, Hirano, Teruyuki, Kamiyama, Kenji, Yagita, Yoshiki, Nagakane, Yoshinari, Hoshino, Haruhiko, Terasaki, Tadashi, Yakushiji, Yusuke, Kudo, Kohsuke, Ihara, Masafumi, Yoshimura, Sohei, Yamaguchi, Yoshitaka, Shiozawa, Masayuki, Toyoda, Kazunori
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856591/
https://ncbi.nlm.nih.gov/pubmed/33598561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2396987320960618
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados